These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16167197)

  • 1. Hepatic encephalopathy: a dynamic or static condition.
    Stewart CA; Cerhan J
    Metab Brain Dis; 2005 Sep; 20(3):193-204. PubMed ID: 16167197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cirrhosis and encephalopathy. Attempt at a physiopathologic interpretation].
    Michel H
    Med Chir Dig; 1976; 5(3):131-8. PubMed ID: 12426
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Sarcopenia and Frailty in Hepatic Encephalopathy Management.
    Lucero C; Verna EC
    Clin Liver Dis; 2015 Aug; 19(3):507-28. PubMed ID: 26195205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume.
    Garcia-Martinez R; Rovira A; Alonso J; Jacas C; Simón-Talero M; Chavarria L; Vargas V; Córdoba J
    Liver Transpl; 2011 Jan; 17(1):38-46. PubMed ID: 21254343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic encephalopathy in patients with cirrhosis: new aspects and practical recommendations].
    Ditisheim S; Spahr L
    Rev Med Suisse; 2010 Sep; 6(261):1667-71. PubMed ID: 20939401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic encephalopathy].
    Hilgard P; Gerken G
    Med Klin (Munich); 2004 Oct; 99(10):591-602. PubMed ID: 15490075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):10S-5S. PubMed ID: 20412035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is minimal hepatic encephalopathy completely reversible following liver transplantation?
    Rose C; Jalan R
    Liver Transpl; 2004 Jan; 10(1):84-7. PubMed ID: 14755783
    [No Abstract]   [Full Text] [Related]  

  • 14. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy.
    Savlan I; Liakina V; Valantinas J
    Medicina (Kaunas); 2014; 50(2):75-81. PubMed ID: 25172600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic encephalopathy as a complication of liver cirrhosis: an Asian perspective.
    Moriwaki H; Shiraki M; Iwasa J; Terakura Y
    J Gastroenterol Hepatol; 2010 May; 25(5):858-63. PubMed ID: 20546438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy.
    Guevara M; Baccaro ME; Gómez-Ansón B; Frisoni G; Testa C; Torre A; Molinuevo JL; Rami L; Pereira G; Sotil EU; Córdoba J; Arroyo V; Ginès P
    J Hepatol; 2011 Sep; 55(3):564-573. PubMed ID: 21163310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion.
    Bajaj JS; Saeian K; Schubert CM; Franco R; Franco J; Heuman DM
    Aliment Pharmacol Ther; 2011 Jul; 34(1):103-5. PubMed ID: 21631553
    [No Abstract]   [Full Text] [Related]  

  • 20. Glutamatergic neurotransmission in hepatic encephalopathy.
    Maddison JE; Watson WE; Johnston GA
    Alcohol Alcohol Suppl; 1993; 2():169-73. PubMed ID: 7538300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.